Market Tracker

05/31 5:16pm ET

ImmunoGen Inc (NASDAQ:IMGN)

5.64
Delayed Data
As of 3:59pm ET
 -0.02 / -0.35%
Today’s Change
5.35
Today|||52-Week Range
19.43
-58.44%
Year-to-Date
No recent news for ImmunoGen Inc.

Today’s Trading

Previous close5.66
Today’s open5.62
Day’s range5.56 - 5.78
Volume1,974,182
Average volume (3 months)1,236,416
Market cap$492.9M
Dividend yield--
Data as of 3:59pm ET, 05/31/2016

Growth & Valuation

Earnings growth (last year)+14.46%
Earnings growth (this year)-116.20%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+42.82%
P/E ratioNM
Price/Sales14.46
Price/Book13.96

Competitors

 Today’s
change
Today’s
% change
ATRAAtara Biotherapeutic...+0.58+3.31%
BPMCBlueprint Medicines ...+0.40+2.15%
CYADCelyad SA+2.75+5.40%
XBITXBiotech Inc+0.97+6.72%
Data as of 3:59pm ET, 05/31/2016

Financials

Next reporting dateJuly 29, 2016
EPS forecast (this quarter)-$0.40
Annual revenue (last year)$85.5M
Annual profit (last year)-$60.7M
Net profit margin-71.01%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mark J. Enyedy
Chief Financial Officer &
Executive Vice President
David B. Johnston
Corporate headquarters
Waltham, Massachusetts

Forecasts